Latest News
Yale researchers learn more about a challenging disease.
- November 06, 2023Source: Medpage Today
Major advances in treatment options have been game-changers for people diagnosed with myasthenia gravis (MG). Experts comment on current MG treatment methods, as well as exciting new research.
- November 03, 2023Source: Medpage Today
Following a wave of new approvals in recent years, adults with generalized myasthenia gravis (gMG) now have a wider variety of treatment options to manage their symptoms.
- April 12, 2023
The Myasthenia Gravis Foundation of America (MGFA) has awarded its Impact Award to Richard Nowak, MD for his exceptional leadership, collaboration, innovation, and dedication to advancing the mission of the MGFA. Dr. Nowak was formally recognized at the 2023 MGFA National Patient Conference in New Orleans, La.
- February 06, 2023Source: NeurologyLive
the Myasthenia Gravis Foundation of America (MGFA) partnered with Alira Health to re-launch its MGFA Global MG Patient Registry. Yale assistant professor Richard Nowak, MD, MGFA’s chief medical advisor, discusses the importance of this registry, which allows MG patients to report their symptoms on a secure platform and informs future clinical trials and advances in treatment.
- December 08, 2022Source: New York Times
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists like Yale assistant professor Richard Nowak, MD, MS, weigh in on the causes, symptoms, and treatment options for this neuromuscular condition, as well as whether or not if affects lifespan.
- December 07, 2022Source: NBC News
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists like Yale assistant professor Richard Nowak, MD, MS weigh in on the causes, symptoms, and treatments of this neuromuscular condition, as well as whether it affects lifespan.
- May 17, 2021
Announcing new roles for Drs. Huned Patwa, Daniel DiCapua, and Hajime Tokuno.
- April 09, 2020Source: NeurologyToday
In an effort to respond to concerns of patients based on available data, a panel of experts has published new guidelines for treating myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) in the setting of the novel coronavirus.
- October 17, 2019
The National Institutes of Health through the Rare Diseases Clinical Research Consortia has awarded a research team from Yale University, George Washington University, and Duke University $7.8 million to establish a rare disease network for myasthenia gravis.